Apollomics, Inc. Announces Initiation of SPARTA Phase 2 Clinical Trial for c-MET Inhibitor APL-101

    NEXT STORY
    Global Hospital Cleaning Chemicals Market Forecast to Grow by $ 2.96 Billion during 2020-2024. Progressing at a CAGR of 9%
    PREV STORY
    Apellis Announces Plans to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Inovio Pharmaceuticals Reports 2018 Second Quarter Financial Results

    PLYMOUTH MEETING, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a ...

    author_avatar
    NASDAQ Market News

    TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007

    REGULATED INFORMATIONPRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May ...

    author_avatar
    NASDAQ Market News

    New Roche data for Evrysdi show improved motor function in pre-symptomatic babies after one year and confirm safety profile in previously treated people with spinal muscular atrophy (SMA)

    author_avatar
    NASDAQ Market News